发明授权
US07186715B2 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
失效
哌嗪和哌啶衍生物作为黑皮质素受体激动剂
- 专利标题： Piperazine- and piperidine-derivatives as melanocortin receptor agonists
- 专利标题（中）： 哌嗪和哌啶衍生物作为黑皮质素受体激动剂
-
申请号： US10466248申请日： 2002-01-23
-
公开(公告)号： US07186715B2公开(公告)日： 2007-03-06
- 发明人: Karin Briner , Christopher William Doecke , Vincent Mancuso , Michael John Martinelli , Timothy Ivo Richardson , Roger Ryan Rothhaar , Qing Shi , Chaoyu Xie
- 申请人： Karin Briner , Christopher William Doecke , Vincent Mancuso , Michael John Martinelli , Timothy Ivo Richardson , Roger Ryan Rothhaar , Qing Shi , Chaoyu Xie
- 申请人地址： US IN Indianapolis
- 专利权人： Eli Lilly and Company
- 当前专利权人： Eli Lilly and Company
- 当前专利权人地址： US IN Indianapolis
- 代理商 Soonhee Jang; James B. Myers
- 国际申请： PCT/US01/00515 WO 20020123
- 国际公布： WO02/059107 WO 20020801
- 主分类号： A61K31/496
- IPC分类号： A61K31/496 ; C07D401/12 ; C07D401/14 ; C07D403/12 ; C07D403/14
摘要：
The present invention relates to melanocortin receptor agonists of formula I, which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction
公开/授权文献
信息查询
IPC分类:
